UK Companies House feature
HOSPIRA UK LIMITED
Profile
- Company number
- 01923357
- Status
- Active
- Incorporation
- 1985-06-18
- Last accounts made up
- 2024-11-30
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The directors have not prepared these financial statements on a going concern basis as they do not believe it is appropriate to do so. This is detailed further in the statement of accounting policies. On 14 December 2018, the company sold its compounded pharmaceutical products business and ceased trading. As the company did not acquire a replacement trade, the directors prepared the 2018, and all subsequent, financial statements on a basis other than going concern. No adjustments were necessary to the amounts at which the assets and liabilities are included in these financial statements.”
Subsidiaries
- Hospira Aseptic Services Ltd · 100% held · United Kingdom · Dormant
Significant events
- “On 14 December 2018, the company sold its compounded pharmaceutical products business and ceased trading.”
- “The company received a dividend from its subsidiary undertaking Hospira Aseptic Services Ltd amounting to £267,056 (2023: £nil). The dividend received has been treated as a return on investment cost for accounting purposes. Hospira Aseptic Services Ltd is currently in liquidation.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 31 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HIGHTON, David Ian | Director | 2021-02-08 | Jul 1968 | British |
| PEARSON, Edwin James | Director | 2017-01-09 | Jan 1974 | British |
Show 31 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BLACKWELL, John David | Secretary | 2002-05-13 | 2004-05-19 |
| BYAM-COOK, David William | Secretary | — | 1998-02-01 |
| FOSTER, Geoffrey Iain | Secretary | 2006-01-16 | 2008-06-04 |
| GILL, Christopher | Secretary | 2008-06-04 | 2009-10-30 |
| GREEN, John Edwin | Secretary | 2004-05-19 | 2006-01-16 |
| JENKINS, Richard Clifford | Secretary | 1998-02-01 | 2002-05-13 |
| JOHANNESEN, Michael B | Secretary | 2008-06-04 | 2015-11-12 |
| O'SULLIVAN, Hannah | Secretary | 2009-10-30 | 2013-01-21 |
| WOODWORTH, Brian Richard | Secretary | 2013-12-17 | 2015-11-13 |
| ANDERSEN, Svend | Director | 2010-11-09 | 2015-09-03 |
| BINFIELD, Paul Andrew | Director | 2005-01-11 | 2007-02-13 |
| FRANKLIN, Ian Eric | Director | 2015-11-25 | 2021-02-09 |
| HOFFMAN, Richard Joseph | Director | 2008-06-04 | 2015-11-26 |
| JAMES, Stuart Bruce | Director | 2002-08-29 | 2005-11-14 |
| KOTSANIS, Michael John | Director | 2007-02-09 | 2010-07-01 |
| MOUNT, Jacqueline Ann | Director | 2021-02-08 | 2022-05-31 |
| NOSEWORTHY, Darren James | Director | 2015-11-25 | 2017-01-09 |
| OSBORN, Ben John | Director | 2019-02-06 | 2022-02-28 |
| REID, Alan Morton | Director | 2002-08-05 | 2005-01-11 |
| RICHARDS, Scott Anthony | Director | 2002-09-29 | 2006-03-31 |
| RICHARDSON, Scott | Director | 2017-02-15 | 2018-03-14 |
| RIENOW, Susan | Director | 2022-02-28 | 2024-10-08 |
| RIENOW, Susan | Director | 2018-03-23 | 2019-02-05 |
| SIMMONS JNR, Billy Joe | Director | 2006-03-08 | 2007-01-30 |
| SMEDLEY, Peter John | Director | 2001-11-22 | 2002-08-28 |
| SOURSAC, Thierry Jean Alphonse, Dr | Director | 2006-03-08 | 2007-01-30 |
| STRATTON, Anthony Hugh | Director | 2005-01-11 | 2015-11-26 |
| SWEBY, Raymond Malcolm | Director | — | 2002-08-05 |
| TULLY, Paula | Director | 2015-11-25 | 2017-02-16 |
| TWEDDELL, Edward Desmond | Director | — | 2001-11-22 |
| WERNER, Thomas Edward | Director | 2007-02-16 | 2008-06-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Pfizer Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2017-04-01 | Active |
| Pfizer Pfe Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2018-04-01 |
Filing timeline
Last 20 of 286 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-11-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-08-05 | AA | accounts | accounts with accounts type full |
| 2024-11-20 | RP04AP01 | officers | second filing of director appointment with name |
| 2024-11-19 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-10-08 | TM01 | officers | termination director company with name termination date |
| 2024-08-08 | AA | accounts | accounts with accounts type full |
| 2024-01-25 | AD01 | address | change registered office address company with date old address new address |
| 2024-01-17 | AD01 | address | change registered office address company with date old address new address |
| 2023-11-30 | SH19 | capital | capital statement capital company with date currency figure |
| 2023-11-30 | SH20 | capital | legacy |
| 2023-11-30 | CAP-SS | insolvency | legacy |
| 2023-11-30 | RESOLUTIONS | resolution | resolution |
| 2023-11-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-06-30 | AA | accounts | accounts with accounts type full |
| 2022-11-22 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-06-10 | AA | accounts | accounts with accounts type full |
| 2022-05-31 | TM01 | officers | termination director company with name termination date |
| 2022-03-09 | AP01 | officers | appoint person director company with name date |
| 2022-03-01 | TM01 | officers | termination director company with name termination date |
| 2021-11-09 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory